Highlights of Ophthalmology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  52 (2024)
Volume  51 (2023)
Volume  50 (2022)
Volume  49 (2021)
Volume  48 (2020)
Volume  47 (2019)
Volume  46 (2018)
Volume  45 (2017)
Volume  44 (2016)
Volume  43 (2015)
Volume  42 (2014)
Volume  41 (2013)
Volume  40 (2012)
Volume  39 (2011)
Volume  38 (2009)
Related articles

VOLUME 43 , ISSUE 6ENG ( December, 2015 ) > List of Articles

REVIEW ARTICLE

Appraisal of Clinical Practice Guidelines for Age-Related Macular Degeneration

Annie M. Wu, Connie M. Wu, Benjamin K. Young, Dominic J. Wu, Paul B. Greenberg, Curtis E. Margo

Citation Information : Wu AM, Wu CM, Young BK, Wu DJ, Greenberg PB, Margo CE. Appraisal of Clinical Practice Guidelines for Age-Related Macular Degeneration. 2015; 43 (6ENG):16-20.

DOI: 10.5005/hoo-10101-43604

Published Online: 27-03-2019

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract
PDF Share
  1. G. A. Stevens, R. A. White, S. R. Flaxman et al., “Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010,” Ophthalmology, vol. 120, no. 12, pp. 2377-2384, 2013.
  2. D. F. Ransohoff, M. Pignone, and H. C. Sox, “How to decide whether a clinical practice guideline is trustworthy,” Journal of the American Medical Association, vol. 309, no. 2, pp. 139-140, 2013.
  3. D. F. Ransohoff and H. C. Sox, “Guidelines for guidelines: measuring trustworthiness,” Journal of Clinical Oncology, vol. 31, no. 20, pp. 2530-2531, 2013.
  4. J. Kung, R. R. Miller, and P. A. Mackowiak, “Failure of clinical practice guidelines to meet institute of medicine standards: two more decades of little, if any, progress,” Archives of Internal Medicine, vol. 172, no. 21, pp. 1628-1633, 2012.
  5. T. M. Shaneyfelt and R. M. Centor, “Reassessment of clinical practice guidelines: go gently into that good night,” The Journal of the American Medical Association, vol. 301, no. 8, pp. 868-869, 2009.
  6. C. Laine, D. B. Taichman, and C. Mulrow, “Trustworthy clinical guidelines,” Annals of Internal Medicine, vol. 154, no. 11, pp. 774-775, 2011.
  7. The AGREE Collaboration, “Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project,” Quality and Safety in Health Care, vol. 12, no. 1, pp. 18-23, 2003.
  8. M. C. Brouwers, M. E. Kho, G. P. Browman, et al., “AGREE II: advancing guideline development, reporting and evaluation in health care,” Canadian Medical Association Journal, vol. 182, no. 18, pp. E839-E842, 2010.
  9. M. C. Brouwers, M. E. Kho, G. P. Browman et al., “Development of the AGREE II, part 1: performance, usefulness and areas for improvement,” Canadian Medical Association Journal, vol. 182, no. 10, pp. 1045-1052, 2010.
  10. . Ou, I. Goldberg, C. Migdal, and P. P. Lee, “A critical appraisal and comparison of the quality and recommendations of glaucoma clinical practice guidelines,” Ophthalmology, vol. 118, no. 6, pp. 1017-1023, 2011.
  11. C. M. Wu, A. M. Wu, B. K. Young, et al., “An evaluation of cataract surgery clinical practice guidelines,” British Journal of Ophthalmology, vol. 99, no. 3, pp. 401-404, 2015.
  12. American Academy of Ophthalmology Retina/Vitreous Panel, Preferred Practice Pattern. Age-Related Macular Degeneration, American Academy of Ophthalmology, San Francisco, Calif, USA, 2008, http://one.aao.org/preferred-practice-pattern/agerelated-macular-degeneration-ppp-september-200.
  13. The Royal College of Ophthalmologists AMD Guidelines Group, Age-Related Macular Degeneration: Guidelines for Management, Royal College of Ophthalmologists, London, UK, 2013, https://www.rcophth.ac.uk/wp-content/uploads/2014/12/2013- SCI-318-RCOphth-AMD-Guidelines-Sept-2013-FINAL.
  14. Institute of Medicine, Clinical Practice Guidelines We Can Trust, The National Academies Press, Washington, DC, USA, 2011.
  15. R. S. A. Hayward, G. H. Guyatt, K.-A. Moore, K. A. McKibbon, and A. O. Carter, “Canadian physicians' attitudes about and preferences regarding clinical practice guidelines,” CMAJ, vol. 156, no. 12, pp. 1715-1723, 1997.
  16. S. Poitras, M. Rossignol, J. Avouac et al., “Management recommendations for knee osteoarthritis: How usable are they?” Joint Bone Spine, vol. 77, no. 5, pp. 458-465, 2010.
  17. L. Vale, R. Thomas, G. MacLennan, and J. Grimshaw, “Systematic review of economic evaluations and cost analyses of guideline implementation strategies,” European Journal of Health Economics, vol. 8, no. 2, pp. 111-121, 2007.
  18. American Academy of Ophthalmology Glaucoma Panel, Preferred Practice Patterns and Ophthalmic Technology Assessments: New Relationship with Industry Procedures, American Academy of Ophthalmology, San Francisco, Calif, USA, 2010.
  19. G. D. Novack, “The role of pharmaceutical companies in sponsored research,” Ophthalmology, vol. 114, no. 6, pp. 1037-1038, 2007.
  20. N. J. Marciano, T. L. Merlin, T. Bessen, and J. M. Street, “To what extent are current guidelines for cutaneous melanoma follow up based on scientific evidence?” International Journal of Clinical Practice, vol. 68, no. 6, pp. 761-770, 2014.
  21. L. Zeng, L. Zhang, Z. Hu et al., “Systematic review of evidence-based guidelines on medication therapy for upper respiratory tract infection in children with AGREE instrument,” PLoS ONE, vol. 9, no. 2, Article ID e87711, 2014.
  22. S. Sabharwal, N. K. Patel, S. Gauher, I. Holloway, and T. Athansiou, “High methodologic quality but poor applicability: assessment of the AAOS guidelines using the AGREE II instrument,” Clinical Orthopaedics and Related Research, vol. 472, no. 6, pp. 1982-1988, 2014.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.